Science News
Medical research, clinical trials, and cannabis studies
Quick Summary
Cannabis research is accelerating as regulatory barriers decrease and institutional support grows. Clinical trials are investigating cannabinoid therapies for conditions ranging from epilepsy to chronic pain. This section covers the latest peer-reviewed studies, FDA research milestones, and breakthroughs in cannabinoid science.
Latest Science Articles
No Science Articles Yet
We're working on bringing you the latest science news. Check back soon.
Browse All NewsNews Categories
Most Read
Cannabis Industry Employment Surpasses 500,000 Jobs Nationwide
Feb 17First Time at a Dispensary: Complete Guide
Feb 24Cannabis Terpenes: Complete Guide to Aromas and Effects
Feb 24Ohio Dispensaries See Record Sales in First Month of Recreational Cannabis
Feb 24Cannabis and Sleep: Can Marijuana Help You Sleep Better?
Feb 24About Science Cannabis News
Cannabis science has entered a new era of rigorous investigation as legalization opens doors for researchers that were previously closed by regulatory barriers. Clinical trials, peer-reviewed studies, and laboratory research are expanding our understanding of how cannabinoids, terpenes, and other plant compounds interact with the human body. From chronic pain management to neurological disorders, the medical potential of cannabis is being explored with increasing scientific precision and institutional support.
The research landscape encompasses a wide range of disciplines including pharmacology, neuroscience, oncology, psychiatry, and agricultural science. Studies examining the endocannabinoid system have revealed complex biological pathways that influence pain perception, inflammation, mood regulation, appetite, and immune function. Meanwhile, clinical trials are testing specific cannabinoid formulations for conditions ranging from epilepsy and multiple sclerosis to anxiety disorders and cancer-related symptoms, generating data that informs both medical practice and regulatory decisions.
Leefii's science news section covers the most significant research developments in cannabis medicine and plant science. We report on newly published studies, ongoing clinical trials, FDA-related research milestones, and breakthroughs in cannabinoid pharmacology. Our coverage also includes agricultural research on cultivation techniques, genetic analysis of cannabis strains, and the evolving science of terpene profiles and their therapeutic contributions. We aim to make complex scientific findings accessible and relevant, helping readers understand how research is shaping the future of cannabis-based medicine and the broader understanding of this plant. Whether you are a patient exploring treatment options, a healthcare provider seeking evidence-based information, or a researcher tracking the field, this section keeps you connected to the science driving cannabis forward.
Frequently Asked Questions
What is the endocannabinoid system?
The endocannabinoid system (ECS) is a biological signaling network found throughout the human body that plays a role in regulating pain, mood, appetite, immune function, and sleep. It consists of endocannabinoids produced by the body, cannabinoid receptors (CB1 and CB2), and enzymes that break down endocannabinoids. Plant cannabinoids like THC and CBD interact with this system.
What FDA-approved cannabis-based medications exist?
The FDA has approved Epidiolex, a CBD-based medication for treating severe forms of epilepsy, and Marinol and Syndros, which contain synthetic THC (dronabinol) for chemotherapy-induced nausea and AIDS-related weight loss. Cesamet, containing synthetic nabilone, is also approved for chemotherapy nausea.
How does CBD differ from THC in medical research?
CBD (cannabidiol) and THC (tetrahydrocannabinol) are both cannabinoids but have different pharmacological profiles. THC is the primary psychoactive compound and is studied for pain relief, nausea reduction, and appetite stimulation. CBD is non-psychoactive and is researched for anti-inflammatory, anti-anxiety, and anti-seizure properties. Both interact with the endocannabinoid system but through different mechanisms.
Why has cannabis research been limited historically?
Cannabis research has been constrained by its Schedule I classification, which requires researchers to obtain special federal licenses and, until recently, limited them to cannabis supplied by a single federally authorized facility at the University of Mississippi. This created significant bureaucratic hurdles, restricted the variety and quality of research material, and limited funding opportunities.
What are terpenes and why do they matter in cannabis science?
Terpenes are aromatic compounds found in cannabis and many other plants that contribute to flavor and scent. Research suggests they may also have therapeutic effects and influence how cannabinoids work through what is known as the entourage effect. Common cannabis terpenes include myrcene, limonene, linalool, and pinene, each associated with different potential benefits such as relaxation, mood elevation, or anti-inflammatory properties.